A new fluorescent imaging probe can for the first time objectively and non-invasively measure loss of smell, clinically known as anosmia. Targeting the olfactory nerve, the new tool has potential to ...
Nanotechnology has revolutionized healthcare by enabling control over materials at the molecular and atomic level. Nanoscale materials exhibit unique ...
Genomic and tumor microenvironment dynamics of brain metastases in breast cancer. ACE-Breast-02: A pivotal phase II/III trial of ARX788, a novel anti-HER2 antibody-drug conjugate (ADC), versus ...
NEW ORLEANS—Heather Jacene, MD, assistant chief of Nuclear Medicine and Molecular Imaging at Brigham and Women’s Hospital, clinical director of Nuclear Medicine at Dana-Farber Cancer Institute, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback